metoclopramide has been researched along with Abdominal Neoplasms in 5 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective trial was performed to better assess the risk of nausea and vomiting and the rescue value of tropisetron (TRO), a 5-HT3 receptor antagonist, in 88 patients undergoing fractionated radiotherapy to the abdomen or to large supradiaphragmatic fields and failing a first anti-emetic trial with metoclopramide (MET)." | 7.69 | Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. ( Behrouz, F; Blazek, N; Coucke, P; Gebhard, S; Melliger, M; Miralbell, R; Philipp, S; Rosset, A; Schwabb, T; Wickenhauser, R, 1995) |
| "A prospective trial was performed to better assess the risk of nausea and vomiting and the rescue value of tropisetron (TRO), a 5-HT3 receptor antagonist, in 88 patients undergoing fractionated radiotherapy to the abdomen or to large supradiaphragmatic fields and failing a first anti-emetic trial with metoclopramide (MET)." | 3.69 | Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. ( Behrouz, F; Blazek, N; Coucke, P; Gebhard, S; Melliger, M; Miralbell, R; Philipp, S; Rosset, A; Schwabb, T; Wickenhauser, R, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, J | 1 |
| Lester, P | 1 |
| Rodrigues, L | 1 |
| Oishi, S | 1 |
| Shimada, T | 1 |
| Sato, T | 1 |
| Miralbell, R | 1 |
| Coucke, P | 1 |
| Behrouz, F | 1 |
| Blazek, N | 1 |
| Melliger, M | 1 |
| Philipp, S | 1 |
| Wickenhauser, R | 1 |
| Gebhard, S | 1 |
| Schwabb, T | 1 |
| Rosset, A | 1 |
| Markman, M | 1 |
| Newman, DR | 1 |
| Hawkins, RS | 1 |
1 trial available for metoclopramide and Abdominal Neoplasms
| Article | Year |
|---|---|
The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
Topics: Abdominal Neoplasms; Adult; Aged; Antiemetics; Double-Blind Method; Humans; Imidazoles; Metocloprami | 1991 |
4 other studies available for metoclopramide and Abdominal Neoplasms
| Article | Year |
|---|---|
Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Colonic Diseases; Dexamethasone; Drug Therapy, | 2016 |
[Case of intrathoracic pheochromocytoma occurring 9 years after resection of intraabdominal paraaortic pheochromocytoma: effect of metoclopramide and sulpiride on catecholamine secretion in vitro].
Topics: Abdominal Neoplasms; Adult; Aorta; Blood Pressure; Catecholamines; Cells, Cultured; Female; Humans; | 1983 |
Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Child; Female; Humans; | 1995 |
Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Cisplatin; Female; Humans; Metoclopramide; Nausea; Ovaria | 1985 |